Loading insider details...
Beta
Latest Form 4 (Aug 26, 2026): Exercise/Conversion of 100,000 ESLA shares, $81.5K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 26, 2026 | Estrella Immunopharma, Inc. (ESLA) | Exercise/Conversion | 100,000 | $81.5K |
| Apr 30, 2026 | Estrella Immunopharma, Inc. (ESLA) | Purchase | 100 | $104.00 |
| Feb 14, 2025 | Estrella Immunopharma, Inc. (ESLA) | Grant/Award | 490,796 | n/a |
| Sep 16, 2024 | Denali Capital Acquisition Corp. (DECA) | Sale | 500,000 | n/a |
| May 24, 2022 | Denali Capital Acquisition Corp. (DECA) | Disposition to Issuer | 93,750 | n/a |
| Apr 13, 2022 | Denali Capital Acquisition Corp. (DECA) | Purchase | 510,000 | $5.10M |